NewDays brings its AI-driven dementia care platform to Nevada, expands seed round to $16M
$16M. That's what NewDays just raised to scale its AI companion for dementia care across six states.
Why it matters
A healthcare AI startup is moving from pilot to regional scale with fresh capital, signaling investor confidence in AI-assisted clinical workflows and the emergence of a new category: AI companions embedded in telehealth platforms for chronic disease management.
The key facts
12 to knowSeed round expanded to $16M
AI companion product named 'Sunny' for mild dementia treatment
Early research shows up to 18 months of cognitive preservation
Expansion across six states, including Nevada
Model combines telehealth clinicians with AI
Seattle-based startup
Seed round: $16M
Company: NewDays (Seattle startup)
AI product: Sunny (companion for dementia care)
Clinical outcome: up to 18 months of cognitive function preservation
Expansion: six states, now including Nevada
Model: telehealth clinicians + AI companion (hybrid)
Go to the source
GeekWiregeekwire.com
Publisher excerpt: Seattle startup NewDays raised $16 million to scale its combination of telehealth clinicians and an AI companion named Sunny for treating mild dementia. Early research shows the platform can help preserve cognitive function by up to 18 months, and the company is now expanding across six states.